First Person Solutions LLC

🌏 Socially responsible vision of bringing relief to Covid sufferers in India
👌 Formula ingredients already proven to have both prophylactic and therapeutic effects on Covid-19
⭐️ Applying for registration in India to sell to an 800-million-person market of current AYUSH users
🎇 Utilizes Molecular Signaling™, an innovative discovery for viral symptoms
🏆 An incredible team of pharmaceutical and biotech startup veterans
💪 $250,000 already invested by founding team
✈️ Future plans include expansion to a large number of other countries
🙌 Molecular Signaling™ can address other viral infections including colds, flu, dengue fever, and Bell’s Palsy.

🌏 Socially responsible vision of bringing relief to tens of millions who cannot afford other treatments
👌 Formula ingredients already proven to have both prophylactic and therapeutic effects on Covid-19
⭐️ Will be applying for AYUSH registration in India to serve an 800-million-person market of current AYUSH users
🎇 Utilizes Molecular Signaling™, an innovative discovery for viral symptoms
🏆 An incredible team of pharmaceutical and biotech startup veterans
💪 $250,000 already invested by founding team
✈️ Future plans include expansion to a large number of other countries
🙌 Molecular Signaling™ can address other viral infections including colds, flu, dengue fever, and Bell’s Palsy.

$150,000
7.5 % Wefunder fee ($11,250)
92.5% Application for AYUSH license in India, formulation and manufacturing in India.  ($138,750)







$250,000
7.5 % Wefunder fee ($18,750)
55.5% Application for AYUSH license in India, formulation, and manufacturing in India. ($138,750)
37% Social Media and Public Relations Marketing in India. ($92,500)





$500,000
7.5 % Wefunder fee ($37,500)
28% Application for AYUSH license in India, formulation, and manufacturing in India. ($138,750)
64.5% Social Media and Public Relations Marketing across multiple provinces in India. ($322,500)